SpringRock Ventures

What SpringRock Ventures does

SpringRock Ventures is a Seattle-based venture capital firm founded with the perspective that healthcare and information technology are converging. The firm invests $2 million to $5 million in early to late-stage, high growth-potential companies across digital health, medical devices, SaaS, services, security, genomics, oral health, and consumerization of healthcare, and reserves a dedicated allocation for seed/EIR-stage oral health innovation. Portfolio emphasis is on companies with demonstrated customer acceptance, with investments sourced primarily through North American deal flow and syndicate partnerships with health system strategics and other VC funds.

The firm is led by Managing Directors Eric Bell and Kirsten Morbeck, supported by five venture partners with operating backgrounds at organizations including Medtronic, Johnson & Johnson, Providence Health & Services, Delta Dental of Washington, and Avalara. SpringRock describes itself as syndicate-friendly, with no minimum ownership percentage and no mandatory board seat requirement, and provides portfolio companies with strategic guidance, executive recruitment, team coaching, and customer and partner introductions. The firm reports that its investment partners have collectively backed 50+ venture-backed companies and achieved 20+ IPOs and acquisitions creating $10B+ in market value.

Recent disclosed activity includes leading Vouched's $17 million Series A (September 2025) and co-investing in Avandra's $17.75 million round (January 2026). The firm is privately held with 1-10 employees and no public revenue disclosure; returns are generated through equity ownership and carried interest from portfolio exits.

Name

SpringRock Ventures

Legal name

SpringRock Ventures

Website

https://springrockventures.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

SpringRock Ventures is a Seattle-based venture capital firm investing $2M-$5M in early to late-stage healthcare and health-IT companies across digital health, medical devices, SaaS, and oral health, with syndicate-friendly terms and no mandatory board seats.

Ownership category

akta.pro rank

Product category

Venture Capital / Healthcare Investment

NAICS

Portfolio Management and Investment Advice (52394), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

Keywords

• Venture capital investing
• Healthcare innovation funding
• Early stage equity investment
• Digital health venture capital
• Medical device investment

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Venture Capital Returns: SpringRock Ventures generates returns through equity investments in early-stage healthcare and technology companies. Returns are realized through IPOs and acquisitions of portfolio companies. Their investment partners have achieved 20+ successful IPOs and acquisitions creating $10B+ market value.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

SpringRock Ventures is a venture capital firm that invests $2 million to $5 million per company in early- to late-stage healthcare and healthcare-IT startups across digital health, SaaS, medical devices, genomics, oral health, HIPAA-compliant services, and consumerization of healthcare. The firm also invests at the seed/EIR stage for oral health innovation and provides portfolio companies with strategic guidance, executive recruitment, team coaching, customer and partner introductions, financing, and milestone oversight.

Product overview

SpringRock Ventures is a venture capital firm that does not offer distinct commercial products or services. The firm provides investment capital (typically $2 million to $5 million per company), strategic guidance, executive recruitment, team coaching, customer and partner introductions, financing, and milestone oversight to early to late-stage healthcare innovation companies. The firm has set aside a special allocation for seed/EIR stage innovation in the oral health sector.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Frazier Healthcare Partners: Pacific Northwest healthcare-dedicated VC firm where Lucinda Stewart previously worked on the investment team. Direct peer as an early-to-growth healthcare investor covering devices, services, and digital health.
• Aegis Ventures: Digital health-focused VC that co-invested with SpringRock in Avandra. Directly comparable as a healthcare-focused early-stage investor building portfolios in imaging, AI, and clinical data infrastructure.
• OVP Venture Partners: Northwest-focused VC where SpringRock Strategic Board Director Lucinda Stewart was previously General Partner and co-leader of the IT practice. Directly comparable as an early-stage healthcare-IT investor with similar sector mix.
• Health Enterprise Partners: Healthcare-focused growth equity firm investing in technology-enabled services and healthcare IT companies. Comparable as an early-to-growth stage investor aligned with SpringRock's healthcare-IT convergence thesis.
• Providence Ventures: Corporate venture arm of Providence Health & Services (where SpringRock Venture Partner Dr. Randy Axelrod was EVP/CCO). Directly comparable as a healthcare-system-backed investor in early-stage digital health and care delivery innovation.
• Echo Health Ventures: Strategic CVC formed by Cambia Health Solutions and Mosaic Health Solutions investing in digital health and care delivery. Comparable as a healthcare-strategic investor partnering with health systems.
• Wavemaker Three-Sixty Health: Early-stage healthcare VC investing across digital health, medical devices, and healthcare services. Comparable as a similarly-sized early-stage healthcare investor with comparable check sizes and stage focus.

Regional players

• Fluke Venture Partners: Kirkland, Washington-based early-stage VC firm led by Senior Managing Director Dennis Weston (a SpringRock Strategic Board Director). Highly comparable as a Pacific Northwest early-stage fund with overlapping healthcare and technology exposure.

Broad incumbents

• Section 32: Healthcare and tech-forward venture firm founded by Bill Maris. Comparable as a healthcare-focused investor with broader sector mandate and significantly larger check sizes than SpringRock.
• OrbiMed Advisors: One of the largest healthcare-dedicated investment firms globally, covering devices, diagnostics, and digital health. Comparable in sector focus but operates at vastly larger fund size and check scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments42 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpringRock Ventures